The B-VITAGE trial: A randomized trial of homocysteine lowering treatment of depression in later life
2011
Correction of B-VITAGE trial vitamin B12 dosage
publication
Author Information
Author(s): Ford Andrew H, Flicker Leon, McCaul Kieran, van Bockxmeer Frank, Hegarty Sarah, Hirani Varsha, Fenner Stephen, Almeida Osvaldo P
Primary Institution: Western Australian Centre for Health & Ageing, Centre for Medical Research, University of Western Australia, Perth, Australia
Conclusion
The correct daily dosage of vitamin B12 used in the B-VITAGE trial is 0.5 mg, not 0.4 mg as previously reported.
Takeaway
The researchers fixed a mistake about how much vitamin B12 was given in a study about treating depression in older people.
Methodology
The trial is a 12-month randomized, double-blind, placebo-controlled study.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website